CNTA
Centessa Pharmaceuticals
CNTA
CNTA
41 hedge funds and large institutions have $350M invested in Centessa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
48% less capital invested
Capital invested by funds: $669M → $350M (-$319M)
Holders
41
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$25M | |
| 2 | +$2.13M | |
| 3 | +$2.1M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$1.05M |
| 5 |
JPMorgan Chase & Co
New York
|
+$846K |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$10.7M | |
| 3 | -$9.45M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.52M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.77M |